| Macrophage migration inhibitory factor (MIF)-based therapeutic concepts in atherosclerosis and inflammation D Sinitski, C Kontos, C Krammer, Y Asare, A Kapurniotu, J Bernhagen Thrombosis and haemostasis 119 (04), 553-566, 2019 | 100 | 2019 |
| Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4 M Lacy, C Kontos, M Brandhofer, K Hille, S Gröning, D Sinitski, ... Scientific reports 8 (1), 5171, 2018 | 60 | 2018 |
| Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting C Kontos, O El Bounkari, C Krammer, D Sinitski, K Hille, C Zan, G Yan, ... Nature Communications 11 (1), 5981, 2020 | 48 | 2020 |
| A MIF‐derived cyclopeptide that inhibits MIF binding and atherogenic signaling via the chemokine receptor CXCR2 C Krammer, C Kontos, M Dewor, K Hille, B Dalla Volta, O El Bounkari, ... Chembiochem 22 (6), 1012-1019, 2021 | 18 | 2021 |
| Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation M Brandhofer, A Hoffmann, X Blanchet, E Siminkovitch, AK Rohlfing, ... Cellular and Molecular Life Sciences 79 (10), 512, 2022 | 17 | 2022 |
| Cross-kingdom mimicry of the receptor signaling and leukocyte recruitment activity of a human cytokine by its plant orthologs D Sinitski, K Gruner, M Brandhofer, C Kontos, P Winkler, A Reinstädler, ... Journal of Biological Chemistry 295 (3), 850-867, 2020 | 15 | 2020 |
| MIF-2/D-DT is an atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis OE Bounkari, C Zan, J Wagner, E Bugar, P Bourilhon, C Kontos, M Zarwel, ... bioRxiv, 2021.12. 28.474328, 2021 | 10 | 2021 |
| Immunotherapy for atherosclerosis—novel concepts S Steffens, C Weber Thrombosis and Haemostasis 119 (04), 515-516, 2019 | 4 | 2019 |
| Recovery and quantification of a myelin oligodendrocyte glycoprotein peptide from rat plasma after protein precipitation C Kontos, ME Androutsou, A Vlamis-Gardikas, T Tselios Analytical biochemistry 538, 71-73, 2017 | 3 | 2017 |
| A high-throughput recovery method for the quantification of a peptide in plasma using HPLC C Kontos, ME Androutsou, T Tselios JOURNAL OF PEPTIDE SCIENCE 22, S100-S100, 2016 | 1 | 2016 |
| Chemokine-selective cxcr4 ectodomain-derived (poly) peptide J Bernhagen, O El Bounkari, A Kapurniotu, C Kontos US Patent App. 18/010,759, 2023 | | 2023 |
| Design, synthesis, and structure-function studies of peptides as inhibitors of the MIF/chemokine receptor axis C Kontos Technische Universität München, 2021 | | 2021 |
| Functional characterization of Arabidopsis thaliana macrophage migration inhibitory factor/D-dopachrome tautomerase-like (AtMDL) proteins and their potential to exert conserved … K Grunert, A Sinitskii, R Brandhofer, G Bourilhon, C Coustau, ... | | 2019 |
| Эволюционная загадка семейства белков ингибирования миграции макрофагов (MIF proteins family is an evolutionary puzzle) D Sinitski, K Gruner, M Brandhofer, C Kontos, P Winkler, A Reinstädler, ... Минск: Экоперспектива, 2019 | | 2019 |
| Identification of an Arg-Leu-Arg motif that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4 C Kontos, M Brandhofer, M Lacy, K Hille, D Sinitski, C Krammer, ... JOURNAL OF PEPTIDE SCIENCE 24, S143-S143, 2018 | | 2018 |
